TACSTD2 and colorectal carcinoma: Furthermore, a biparametric analysis of Trop-2/CD9 in CRC identified subgroups where patients with high levels of both proteins had a significantly higher risk of metastatic relapse compared to those with low levels of Trop-2 and CD9 [62].